Lithium: The Basics

Today, we will discuss GLP-1's and the emerging use of this class of medications in psychiatry.Sources:https://pubmed.ncbi.nlm.nih.gov/42247271/https://pmc.ncbi.nlm.nih.gov/articles/PMC11441540/https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2838205https://pubmed ... Show More

We resume our landmark studies series looking at the pivotal study in Major Depressive Disorder (MDD), The STAR*D (Sequenced Treatment Alternatives to Relieve Depression) trial.References:https://pubmed.ncbi.nlm.nih.gov/12778843/https://pubmed.ncbi.nlm.nih.gov/19880458/https://ja ... Show More

We have a special guest today to talk about one of our favorite topics... dogs! Most people might intuitively say that they feel like their dogs improve their mental health, but today, we look at the science with the leading expert on the subject. Dr. Nancy Gee Profile: https://m ... Show More

Welcome to PsychEd — the psychiatry podcast for medical learners, by medical learners. This episode is an introduction to the use and monitoring of lithium in bipolar disorder. Join Tingting Yan (CC4) and Dr. Alex Raben (staff psychiatrist at CAMH and lecturer at the University o ... Show More

This podcast reviews the pharmaceutical class lithium salts. Drug action and a mnemonic for common side-effects are presented. 

In the final episode of our psychopharmacology basics series, we are going to discuss commonly used mood stabilizers including lithium, valproic acid, lamotrigine, carbamazepine, and oxcarbazepine. What conditions are they used for? How do they work? What are their side effect pr ... Show More

It’s the lightest metal on the periodic table. Its origins lie in the very beginnings of our universe. And it's taken, in the form of a pill, by thousands of Australians every day. Join us as we dive deep into the story of this wonder element lithium — the magic ion, as it's some ... Show More

<p>We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-c ... Show More

Join us for a candid and insightful discussion with two leading experts: Dr. Christina Riachi, a clinical psychologist, and Dr. Fady Maalouf, psychiatrist and Chairperson at AUBMC. They'll demystify the use of psychiatric medications, exploring the pros, cons, and crucial convers ... Show More

In this episode, we review the high-yield topic of Psychotherapy from the Psychiatry section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbulletsIn this episode 

On this episode, I breakdown the Selective Serotonin Reuptake Inhibitors. They are the first line medication often used in the management of depression, anxiety, OCD, and other mental health disorders. I talk about drug interactions and the subtle differences between the agents. ... Show More